A trial to Determine the Optimal early mobility Training after Stroke AVERT DOSE: A trial to Determine the Optimal early…
A Study of BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel AXIOMATIC-SSP: A Study of…
A randomised controlled trial of DIRECT endovascular clot retrieval versus standard bridging thrombolysis with endovascular clot retrieval within 4.5 hours…
A Multicentre, Randomised, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects…
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants with…
Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment Lead PI: Prof Timothy Kleinig Status: ASTN endorsed, Site selection, Recruiting…
Improving early reperfusion with adjuvant dornase alfa in large vessel ischemic stroke. An umbrella Bayesian optimized phase 2 trial of…
Extending the time for thrombolysis in emergency neurological deficits – intra-arterial with tenecteplase Lead PI: Dr Bruce Campbell Status: Closed No. of…
Determining the Optimal Dose of Tenecteplase Before Endovacular Therapy for Ischaemic Stoke (EXTEND-IA TNK Part 2) Lead PI: Dr Bruce Campbell…
A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor…
A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of…